Literature DB >> 8632561

Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy.

S A Kaplan1, D L Bowers, A E Te, C A Olsson.   

Abstract

PURPOSE: We determined the incidence of voiding symptoms, urodynamic etiology and satisfaction with therapy in a large cohort of men with prostatism during a 12-year period.
MATERIALS AND METHODS: We retrospectively analyzed the records of 2,845 consecutive men who underwent urodynamic evaluation between January 1982 and December 1994. Patients were divided into groups 1 and 2 according to the years of study (between 1982 and 1988, and between 1989 and 1994, respectively). Parameters of evaluation included prevalence and distribution of voiding symptoms, urodynamic etiology of symptoms and satisfaction with therapy (medical or surgical).
RESULTS: There was 843 evaluable patients 50 to 94 years old (mean age 63.2) Group 2 patients were younger, and had a 22% higher prevalence of nocturia and a 12% higher prevalence of daytime frequency. The prevalence of all other symptoms was the same in both groups. On urodynamics 523 patients (62%) had demonstrable evidence of bladder outlet obstruction of whom 345 (66%) had concomitant detrusor instability. Of the 843 patients 647 (77%) had detrusor instability, which was the sole diagnosis in 199 (24%). We noted low pressure/low flow in 137 patients (16%) and impaired detrusor contractility in 152 (17%), including 57 (7%) in whom the latter condition was the only diagnosis. Urodynamic findings remained the same during the entire 12-year period. Global satisfaction and symptomatic improvement were better with surgical than medical therapy, although the degree of satisfaction was independent of the urodynamic etiology of symptoms.
CONCLUSIONS: Symptomatic men with prostatism are presenting with a greater prevalence of significant nocturia and daytime frequency than in the past with no change in urodynamic findings. In addition, patient level of satisfaction remains greater with surgical than medical therapy regardless of the urodynamic presence of bladder outlet obstruction.

Entities:  

Mesh:

Year:  1996        PMID: 8632561     DOI: 10.1016/s0022-5347(01)66252-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Male overactive bladder: the role of urodynamics and anticholinergics.

Authors:  Scott MacDiarmid; Alexandra Rogers
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

2.  Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

3.  Urodynamic characterization of lower urinary tract symptoms in men less than 40 years of age.

Authors:  Asha E Jamzadeh; Donghua Xie; Melissa Laudano; Stephan Seklehner; Dean S Elterman; Lucien Shtromvaser; Richard Lee; Steven A Kaplan; Alexis E Te; Bilal Chughtai
Journal:  World J Urol       Date:  2013-07-25       Impact factor: 4.226

4.  Long-term alpha-blockers and anticholinergic combination treatment for men with lower urinary tract symptoms in real-life practice.

Authors:  Woong Jin Bae; Jang Ho Bae; Yong Sun Choi; Su Jin Kim; Hyuk Jin Cho; Sung Hoo Hong; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee
Journal:  Int Urol Nephrol       Date:  2012-04-15       Impact factor: 2.370

Review 5.  Combination antimuscarinics and alpha-blockers for benign prostatic hyperplasia.

Authors:  Scott A MacDiarmid
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

Review 6.  Overactive bladder and men: indications for anticholinergics.

Authors:  Ricardo R González; Alexis E Te
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

Review 7.  The role of urodynamics in the diagnosis and treatment of benign prostatic hyperplasia.

Authors:  J Quentin Clemens
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

8.  Transitional zone index and intravesical prostatic protrusion in benign prostatic hyperplasia patients: correlations according to treatment received and other clinical data.

Authors:  Tao Huang; Jun Qi; Yongjiang Yu; Ding Xu; Yang Jiao; Jian Kang; Yunkai Zhu; Yaqing Chen
Journal:  Korean J Urol       Date:  2012-04-18

Review 9.  Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment.

Authors:  William I Jaffe; Alexis E Te
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.